bims-minfam Biomed News
on Inflammation and metabolism in ageing and cancer
Issue of 2024–09–22
two papers selected by
Ayesh Seneviratne, Western University



  1. Nat Aging. 2024 Sep 16.
    Biomarkers of Aging Consortium
      Biomarkers of aging (BOA) are quantitative parameters that predict biological age and ideally its changes in response to interventions. In recent years, many promising molecular and omic BOA have emerged with an enormous potential for translational geroscience and improving healthspan. However, clinical translation remains limited, in part due to the gap between preclinical research and the application of BOA in clinical research and other translational settings. We surveyed experts in these areas to better understand current challenges for the translation of aging biomarkers. We identified six key barriers to clinical translation and developed guidance for the field to overcome them. Core recommendations include linking BOA to clinically actionable insights, improving affordability and availability to broad populations and validation of biomarkers that are robust and responsive at the level of individuals. Our work provides key insights and practical recommendations to overcome barriers impeding clinical translation of BOA.
    DOI:  https://doi.org/10.1038/s43587-024-00683-3
  2. JACC Basic Transl Sci. 2024 Aug;9(8): 968-970
      
    Keywords:  clonal hematopoiesis; dilated cardiomyopathy; genetics; heart failure
    DOI:  https://doi.org/10.1016/j.jacbts.2024.06.002